Literature DB >> 17587636

Effects of zonisamide on experimental tremors in rats.

Hideto Miwa1, Kiwa Hama, Yoshinori Kajimoto, Tomoyoshi Kondo.   

Abstract

OBJECTS: To study the effect of zonisamide on experimental tremors in rats.
METHODS: Effect of zonisamide on harmaline- or oxotreorine-induced tremors, and tacrine-induced tremulous jaw movements (TJMs) was studied.
RESULTS: Zonisamide significantly suppressed both harmaline- and oxotremorine-induced tremors dose-dependently. Zonisamide also significantly suppressed tacrine-induced TJMs, and this effect was not lost under conditions of monoamine-depletion or dopaminergic blockade.
CONCLUSION: The anti-tremor effects of zonisamide may be achieved by a non-dopaminergic mechanism. Since it effectively suppressed tremors that are based on different kinds of tremors, we propose a novel perspective of clinical potential of zonisamide as a non-specific, anti-tremor drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587636     DOI: 10.1016/j.parkreldis.2007.05.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  9 in total

1.  Dramatic response to zonisamide of post-subarachnoid hemorrhage Holmes' tremor.

Authors:  S Suda; M Yamazaki; K Katsura; T Fukuchi; N Kaneko; M Ueda; H Nagayama; Y Katayama
Journal:  J Neurol       Date:  2011-06-07       Impact factor: 4.849

2.  T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor.

Authors:  Adrian Handforth; Gregg E Homanics; Douglas F Covey; Kathiresan Krishnan; Jae Yeol Lee; Kenji Sakimura; Fredricka C Martin; Arnulfo Quesada
Journal:  Neuropharmacology       Date:  2010-06-12       Impact factor: 5.250

Review 3.  Diagnosis and treatment of common forms of tremor.

Authors:  Andreas Puschmann; Zbigniew K Wszolek
Journal:  Semin Neurol       Date:  2011-02-14       Impact factor: 3.420

Review 4.  T-type calcium channel as a new therapeutic target for tremor.

Authors:  Hideto Miwa; Tomoyoshi Kondo
Journal:  Cerebellum       Date:  2011-09       Impact factor: 3.847

5.  Anatomical localization of Cav3.1 calcium channels and electrophysiological effects of T-type calcium channel blockade in the motor thalamus of MPTP-treated monkeys.

Authors:  Annaelle Devergnas; Erdong Chen; Yuxian Ma; Ikuma Hamada; Damien Pittard; Stefan Kammermeier; Ariana P Mullin; Victor Faundez; Craig W Lindsley; Carrie Jones; Yoland Smith; Thomas Wichmann
Journal:  J Neurophysiol       Date:  2015-11-04       Impact factor: 2.714

6.  A mechanistic approach to explore the neuroprotective potential of zonisamide in seizures.

Authors:  Baldeep Kumar; Bikash Medhi; Manish Modi; Biman Saikia; Savita Verma Attri; Ajay Patial
Journal:  Inflammopharmacology       Date:  2018-04-11       Impact factor: 4.473

Review 7.  The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical Data.

Authors:  Babak Tousi; James B Leverenz
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

8.  Pharmacological and physiological characterization of the tremulous jaw movement model of parkinsonian tremor: potential insights into the pathophysiology of tremor.

Authors:  Lyndsey E Collins-Praino; Nicholas E Paul; Kristen L Rychalsky; James R Hinman; James J Chrobak; Patrick B Senatus; John D Salamone
Journal:  Front Syst Neurosci       Date:  2011-07-04

9.  Harmaline tremor: underlying mechanisms in a potential animal model of essential tremor.

Authors:  Adrian Handforth
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.